Metal radionuclide labeled proteins for diagnosis and therapy

Details Metal radionuclide labeled proteins for diagnosis and therapy Metal radionuclide labeled proteins for diagnosis and therapy

1987-06-19

1990-01-30

Maples, John S.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

530390, 530391, 530404, 530405, A61K 4902, A61K 39395

Patent

active

048972550

ABSTRACT:
Protein conjugated chelated metal radionuclides are provided for use in vivo. Intermediates are provided for preparing the polypeptide compositions efficiently.

REFERENCES:
patent: Re32417 (1987-05-01), Burchiel et al.
patent: 3974268 (1976-08-01), Subramanian et al.
patent: 3987157 (1976-10-01), Molinski et al.
patent: 3989730 (1976-11-01), Subramanian et al.
patent: 4017595 (1977-04-01), Subramanian et al.
patent: 4027005 (1977-05-01), Adler et al.
patent: 4032625 (1977-06-01), Subramanian et al.
patent: 4115541 (1978-09-01), Subramanian et al.
patent: 4208398 (1980-06-01), Kubiatowicz et al.
patent: 4232000 (1980-11-01), Fawzi
patent: 4233284 (1980-11-01), Fawzi
patent: 4233285 (1980-11-01), Winchell et al.
patent: 4287362 (1981-09-01), Yokoyama et al.
patent: 4331647 (1982-05-01), Goldenberg
patent: 4348376 (1982-09-01), Goldenberg
patent: 4352751 (1982-10-01), Wieder et al.
patent: 4361544 (1982-11-01), Goldenberg
patent: 4363793 (1982-12-01), Blau et al.
patent: 4416865 (1983-11-01), Rhodes et al.
patent: 4418052 (1983-11-01), Wong
patent: 4421735 (1983-12-01), Haber et al.
patent: 4434151 (1984-02-01), Byrne et al.
patent: 4444690 (1984-04-01), Fritzberg
patent: 4444744 (1984-04-01), Goldenberg
patent: 4454106 (1984-06-01), Gansow et al.
patent: 4460559 (1984-07-01), Goldenberg
patent: 4460561 (1984-07-01), Goldenberg
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4474746 (1984-10-01), Blau et al.
patent: 4479930 (1984-10-01), Hnatowich
patent: 4497744 (1985-02-01), Fawzi
patent: 4510125 (1985-04-01), Grogg et al.
patent: 4564472 (1986-01-01), Ueda et al.
patent: 4571430 (1986-02-01), Byrne et al.
patent: 4575556 (1986-03-01), Byrne et al.
patent: 4582700 (1986-04-01), Dean et al.
patent: 4615876 (1986-10-01), Troutner et al.
patent: 4624846 (1986-11-01), Goldenberg
patent: 4634586 (1987-01-01), Goodwin et al.
patent: 4636380 (1987-01-01), Wong
patent: 4638051 (1987-01-01), Burns et al.
patent: 4652440 (1987-03-01), Paik et al.
patent: 4652519 (1987-03-01), Warshawsky et al.
patent: 4659839 (1987-04-01), Nicolotti et al.
patent: 4665897 (1987-05-01), Lemelson
patent: 4666697 (1987-05-01), Takahashi et al.
patent: 4670545 (1987-06-01), Fritzberg et al.
patent: 4671958 (1987-06-01), Rodwell et al.
patent: 4673562 (1987-06-01), Davison et al.
patent: 4678667 (1987-07-01), Meares et al.
K. E. Baidoo, "Synthesis of Tc-99m-N.sub.2 S.sub.2 Complexes Via the p-Methoxy benzyl Protected Thiol Ligand", J. Nuc. Med., vol. 27, No. 6, Jun. 1986.
B. Bubeck, "Clinical Comparison of I-131 o-Iodohippurate with Tc-99 CO.sub.2 -DADS-A and Tc-99m MAG.sub.3 by Simultaneous Double Tracer Measurement", Nuc Compact, 17, pp. 135-138 (1986).
F. Chen, "A Bifunctional Ligand for Pd(II)", Nucl. Med. Biol., vol. 1, No. 4, pp. 369-372, 1986.
R. L. Childs, "Optimum Conditions for Labeling of DTPA-Coupled Antibodies with Technetium 99m", J. Nucl. Med., 26, pp. 293-299 (1985).
A. R. Fritzberg, "Advances in 99mTc-Labeling of Antibodies", Nucl. Med., 26, pp. 7-12 (1987).
A. R. Fritzberg, "Synthesis and Characterization of Re and Tc Complexes of N.sub.2 S.sub.2 and N.sub.3 S Ligands", 6th Intrntl. Symp. on Radiopharm. Chem., Boston, 1986.
Fritzberg et al., "Labeling of Proteins by Chelate Conjugation with Tc-99m and Re-188", Amer. Chem. Soc. Abstracts, Apr. 1984, Abstract No. 70.
Fritzberg et al., "Radiolabeling of Antibodies with Tc-99m Using N.sub.2 S.sub.2 Ligands", J. Nuc. Med., vol. 27, No. 6, Jun. (1986), Abstract No. 330.
Fritzberg et al., "Synthesis and Biological Evaluation of Technetium 99m MAG.sub.3 as a Hippuran Replacement", J. Nucl. Med., 27, pp. 111-116 (1986).
Fritzberg et al., "Radio-HPLC: Application to Organics and Metal Chelate Chemistry", Analytical and Chromatographic Techniques in Radiopharmaceutical Chemistry, ed. Wieland, Springer-Verlag, New York Inc., 1986.
Johnson et al., "Stereochemical Studies in the Development of Technetium Radiopharmaceuticals. 1, Fluxional Racemization of Technetium and Rhenium Penicillamine Complexes", Inorganic Chem., 23, pp. 4204-4207 (1984).
S. Kasina, "Application of Diamide Dimercaptide N.sub.2 S.sub.2 Bifunctional Chelating Agents for 99mTc-Labeling of Proteins", 6th International Symp. on Radiopharmaceutical Chem., Boston, 1986.
Kasina et al., "Tissue Distribution Properties of Technetium-99m-Diamide-Dimercaptide Complexes and Potential Use as Renal Radiopharmaceuticals", J. Med. Chem., 29, pp. 1933-40 (1986).
Kozak et al., "Bismuth-212-Labeled Anti-Tac monoclonal Antibody: alpha-Particle-Emitting Radionuclides as Modalities for Radioimmunotherapy", Proc. Natl. Acad. Sci., USA, vol. 83, pp. 474-478, Jan. 1986.
Kronauge, et al., "Isonitrile Ester Complexes of Technetium", J. Nucl. Med., vol. 27, No. 6, Jun. (1986), Abstract No. 74.
A. C. Morgan et al., "Production and Characterization of Monoclonal Antibody to a Melanoma Specific Glycoprotein", Hybridoma, vol. 1, No. 1 (1981).
D. L. Nosco, et al., "Characterization of the New [Tc-99M], Dynamic Renal Imaging Agent: [Tc-99m], MAG.sub.3 ", J. Nucl. Med., vol. 27, No. 6, Jun. (1986), Abstract No. 256.
Taylor, et al., "Preliminary Evaluation of 99m-Tc Mercaptoacetyltriglycine as a Replacement for .sup.131 I OIH", Contr. Nephrol., vol. 56, No. 5 (1986).
Taylor, et al.., "Comparison of Tc-99m Mercaptoacetyltriglycine (MAG.sub.3) and OIH in Normal Subjects and Patients", J. Nucl. Med., vol. 27, No. 6, Jun. (1986), Abstract No. 351.
Taylor et al., "Preliminary Evaluation of 99m-Tc Mercaptoacetyltriglycine as a Replacement for .sup.131 I OIH", J. Nuc. Med., vol. 27, No. 4, Apr. 1986.
R. de Jong, "Results of ERBF and ERPF Measurements in Healthy Dogs with Two New Radiopharmaceutical Principles", J. Nuc. Med., vol. 27, No. 4 Apr. (1986).
H. W. Goldfarb, "Comparison of Tc-99m Aminoethyl Diaminodithiol Analogues for Brain Blood Flow Imaging", J. Nuc. Med., vol. 27, No. 6, Jun. 1986, Abstract No. 716.
H. F. Kung, "New Tc-99 Complexes Based on N.sub.2 S.sub.2 Ligands", J. Nuc. Med., vol. 27, No. 6, Jun. 1986, Abstract No. 719.
A. R. Fritzberg et al., "Chemical and Biological Studies of Tc-99m N, N.sup.1 -Bis(mercaptoacetamido)-ethylenediamine: A Potential Replacement for I-131 Iodohippurate", J. Nucl. Med., 22, pp. 258-63 (1981) [Fritzberg et al. II].
C. Muller-Suur, et al., "Clearance and Renal Extraction of a New Renal Scanning Agent:", Techn tium-99m MAG.sub.3 in Comparison to Hippurate (OIH) and EDTA.
F. Liang, "Serum-Stability and Non-Specific Binding of Technetium-99m Labeled Diaminodithiol for Protein Labeling", J. Nuc. Med., vol. 27, No. 6, Jun. 1896, Abstract No. 720.
Chiotellis et al., "Comparative Biodistribution of 99m Tc-Labeled Polyaminodithiol Derivatives", J. Nuc. Med., vol. 27, No. 6, Jun., 1986, Abstract No. 715.
Verbruggen et al., J. of Nuc. Med., vol. 27, No. 6, Jun. 1986, Abstract No. 76.
C. E. Costello et al., "The Investigation of Radiopharmaceutical Components by Fast Atom Bombardment Mass Spectrometry=The Identification of Tc-HIDA and the Epimers of Tc-CO.sub.2 DADS", J. Nucl. Med., 24, pp. 353-355 (1983).
A. Davison et al., "A New Class of Oxotechnetium (5+) Chelate Complexes Containing a TcON.sub.2 S.sub.2 Core", Inorganic Chem., 20, pp. 1629-1630 (1981).
A. R. Fritzberg, "Current Status of Renal Radiopharmaceuticals", J. Nucl. Med. Tech., pp. 177-188 (1984).
A. R. Fritzberg et al., "Synthesis and Biological Evaluation of Tc-99M N,N'-Bis(mercaptoacetyl)-2,3-diaminopropanoate: A Potential Replacement for [.sup.131 I]o-iodohippurate", J. Nucl. Med., 23, pp. 592-598 (1982) [Fritzberg et al., I].
A. R. Fritzberg et al., "Tc-99m Complexes Based on Diamide Dimercap Tide Donor Groups (N.sub.2 S.sub.2) as Potential Renal Function Agents", J. Nucl. Med. Prac. 29th Ann. Meeting, pp. 17 [Fritzberg et al., III.
O. A. Gransow et al., "Generator-Produced Bi-212 Chelated to Chemically Modified Monoclonal Antibody for Use in Radiotherapy", Amer. Chem. Soc. Symp. Ser., 241, pp. 215-217 (1984).
B. A. Khaw et al., "Technetium-99m Labeling of Antibodies to Cardiac Myosin Fab and to Human Fibrinogen", J. Nucl. Med., 23, pp. 1011-1019 (1982).
C. F. Meares et al., "Conjugation of Antibodies with Bifunction

Affiliated with

Also associated with

Rating

Metal radionuclide labeled proteins for diagnosis and therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Metal radionuclide labeled proteins for diagnosis and therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metal radionuclide labeled proteins for diagnosis and therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1922717